fingolimod hydrochloride has been researched along with Carcinoma, Squamous Cell of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Chou, K; Meng, Q; Xie, C; Zhao, L | 1 |
| Chen, MC; Chiang, SL; Hua, CH; Ko, YC; Lee, CH; Lin, SH; Velmurugan, BK; Yeh, KT | 1 |
2 other study(ies) available for fingolimod hydrochloride and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Inhibitory Effect of Fingolimod on Head and Neck Squamous Cell Carcinoma and Its Mechanism: Gene Set Enrichment Analysis.
Topics: Cyclins; Fingolimod Hydrochloride; Head and Neck Neoplasms; Humans; Ki-67 Antigen; Squamous Cell Carcinoma of Head and Neck | 2023 |
PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Female; Fingolimod Hydrochloride; Glycogen Synthase Kinase 3 beta; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Phosphorylation; Proportional Hazards Models; Protein Phosphatase 2; Risk Factors; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tyrosine | 2018 |